• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过草药配方和纳米多草药配方治疗银屑病:一种新方法。

The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: A new approach.

作者信息

Yadav Tejpal, Yadav Hemant Kumar Singh, Raizaday Abhay, Alam Md Sabir

机构信息

Gyan Vihar School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India.

Department of Pharmaceutics, College of Pharmacy, JSS Academy of Technical Education, Noida, Uttar Pradesh, India.

出版信息

Bioimpacts. 2024 Aug 11;15:30341. doi: 10.34172/bi.30341. eCollection 2025.

DOI:10.34172/bi.30341
PMID:40256226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12008506/
Abstract

Psoriasis is a chronic condition that can strike at any age. This sickness is associated with inflammatory problems that impact all humans in the world. Psoriasis is more common in Scandinavians than in Asian and African populations due to a combination of factors such as age, gender, geographic location, ethnicity, genetic and environmental factors. Immune stimulation, genetic contribution, antimicrobial peptides, and other significant triggers such as medicines, immunizations, infections, trauma, stress, obesity, alcohol intake, smoking, air pollution, sun exposure, and particular disorders cause psoriasis. Numerous clinical research investigations are now underway, and therapeutic alternatives are available. However, these therapies only improve symptoms and do not accomplish a complete cure; they also have dangerous and undesirable side effects. Natural products have gained popularity recently due to their great effectiveness, safety, and low toxicity. Natural formulations of various nanocarriers like liposomes, lipospheres, nanogels, emulgel, nanostructured lipid carriers, nanosponge, nanofibers, niosomes, nanomiemgel, nanoemulsions, nanospheres, cubosomes, microneedles, nanomicelles, ethosomes, nanocrystals, and foams, have significantly contributed and encouraged advancement in psoriasis disease treatment. These phytochemical-loaded new nanoformulations address several issues associated with natural products in conventional dosage forms, such as instability, poor solubility, and limited bioavailability. This article reviews some of the intriguing phytochemicals, as well as their possible molecular target locations and mechanisms of action, which may assist in the development of more specific and selective antipsoriatic medicines. Exploring and understanding phytochemicals' functions will allow for more site-specific psoriasis treatment techniques. This review concluded the psoriasis disease with phytoconstituent loaded herbal or polyherbal nanocarriers and their mechanistic approach.

摘要

银屑病是一种可在任何年龄发病的慢性疾病。这种疾病与影响全世界所有人的炎症问题相关。由于年龄、性别、地理位置、种族、遗传和环境等多种因素的综合作用,银屑病在斯堪的纳维亚人中比在亚洲和非洲人群中更为常见。免疫刺激、遗传因素、抗菌肽以及其他重要诱因,如药物、免疫接种、感染、创伤、压力、肥胖、酒精摄入、吸烟、空气污染、阳光照射和某些疾病,都会引发银屑病。目前正在进行大量的临床研究调查,并且有多种治疗选择。然而,这些疗法仅能改善症状,无法实现完全治愈;它们还具有危险且不良的副作用。天然产物近来因其高效、安全和低毒性而受到欢迎。各种纳米载体的天然制剂,如脂质体、脂质球、纳米凝胶、乳胶、纳米结构脂质载体、纳米海绵、纳米纤维、非离子表面活性剂囊泡、纳米微凝胶、纳米乳液、纳米球、立方液晶、微针、纳米胶束、醇质体、纳米晶体和泡沫,对银屑病疾病治疗的进展做出了重大贡献并起到了推动作用。这些负载植物化学物质的新型纳米制剂解决了传统剂型中天然产物存在的几个问题,如稳定性差、溶解度低和生物利用度有限等。本文综述了一些有趣的植物化学物质,以及它们可能的分子靶点位置和作用机制,这可能有助于开发更具特异性和选择性的抗银屑病药物。探索和理解植物化学物质的功能将有助于实现更针对特定部位的银屑病治疗技术。本综述总结了负载植物成分的草药或多草药纳米载体治疗银屑病疾病及其作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/761fd594386e/bi-15-30341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/cc39fc1fb820/bi-15-30341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/6f1b263c72ba/bi-15-30341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/761fd594386e/bi-15-30341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/cc39fc1fb820/bi-15-30341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/6f1b263c72ba/bi-15-30341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f8/12008506/761fd594386e/bi-15-30341-g003.jpg

相似文献

1
The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: A new approach.通过草药配方和纳米多草药配方治疗银屑病:一种新方法。
Bioimpacts. 2024 Aug 11;15:30341. doi: 10.34172/bi.30341. eCollection 2025.
2
Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis.天然产物及新型药物递送系统在银屑病治疗中的应用进展
Front Pharmacol. 2021 Apr 21;12:644952. doi: 10.3389/fphar.2021.644952. eCollection 2021.
3
New Insights in Psoriasis Management using Herbal Drug Nanocarriers.中药纳米载体在银屑病治疗中的新见解。
Curr Pharm Des. 2024;30(32):2550-2561. doi: 10.2174/0113816128330298240708110336.
4
Exploring the potential of nanocarriers in antipsoriatic therapeutics.探索纳米载体在抗银屑病治疗中的潜力。
J Dermatolog Treat. 2022 Nov;33(7):2919-2930. doi: 10.1080/09546634.2022.2089616. Epub 2022 Jun 21.
5
Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.纳米载体介导的局部给药治疗银屑病
Curr Drug Metab. 2017;18(5):454-468. doi: 10.2174/1389200218666170222145240.
6
A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management.纳米技术进展与纳米载体在银屑病治疗中的应用全览。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 23. doi: 10.1007/s00210-025-03804-w.
7
A Promising Approach of Dermal Targeting of Antipsoriatic Drugs Engineered Nanocarriers Drug Delivery Systems for Tackling Psoriasis.用于治疗银屑病的抗银屑病药物皮肤靶向的一种有前景的方法:工程化纳米载体药物递送系统
Drug Metab Bioanal Lett. 2023;16(2):89-104. doi: 10.2174/2949681016666230803150329.
8
Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches.用于银屑病的新型胶体载体:当前问题、机制见解和新型递药方法。
J Control Release. 2013 Sep 28;170(3):380-95. doi: 10.1016/j.jconrel.2013.05.020. Epub 2013 Jun 13.
9
Understanding the prospective of nano-formulations towards the treatment of psoriasis.了解纳米制剂在治疗银屑病方面的前景。
Biomed Pharmacother. 2018 Nov;107:447-463. doi: 10.1016/j.biopha.2018.07.156. Epub 2018 Aug 10.
10
Novel Herbal Nanocarriers for Treatment of Dermatological Disorders.新型草药纳米载体治疗皮肤疾病。
Pharm Nanotechnol. 2022 Nov 15;10(4):246-256. doi: 10.2174/2211738510666220622123019.

引用本文的文献

1
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products.天然产物治疗代谢功能障碍相关脂肪性肝病的新方法。
ILIVER. 2024 Nov 8;3(4):100131. doi: 10.1016/j.iliver.2024.100131. eCollection 2024 Dec.
2
Tapinarof Nanogels as a Promising Therapeutic Approach.他扎罗汀纳米凝胶作为一种有前景的治疗方法。
Pharmaceutics. 2025 Jun 1;17(6):731. doi: 10.3390/pharmaceutics17060731.

本文引用的文献

1
Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.在空腹和餐后状态下,中国健康受试者中阿普米司特片的药代动力学和生物等效性。
Drug Des Devel Ther. 2024 Jun 14;18:2273-2285. doi: 10.2147/DDDT.S461771. eCollection 2024.
2
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.比美吉珠单抗治疗斑块状银屑病的疗效与安全性:专家共识小组
Dermatol Ther (Heidelb). 2024 Feb;14(2):323-339. doi: 10.1007/s13555-024-01099-y. Epub 2024 Feb 10.
3
A randomized, controlled pilot study of oral roflumilast compared with intramuscular methotrexate for plaque and scalp psoriasis.
一项口服罗氟司特与肌肉注射甲氨蝶呤治疗斑块状和头皮银屑病的随机对照试验性研究。
J Am Acad Dermatol. 2024 May;90(5):1063-1065. doi: 10.1016/j.jaad.2024.01.018. Epub 2024 Jan 22.
4
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).比美吉珠单抗治疗斑块状银屑病的有效性和安全性:一项真实世界多中心研究-IL PSO(意大利银屑病情况)
Front Med (Lausanne). 2023 Aug 8;10:1243843. doi: 10.3389/fmed.2023.1243843. eCollection 2023.
5
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO).口服罗氟司特治疗中重度银屑病的疗效和安全性——一项随机对照试验(PSORRO)
Lancet Reg Health Eur. 2023 Apr 21;30:100639. doi: 10.1016/j.lanepe.2023.100639. eCollection 2023 Jul.
6
Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis.氘可来昔替尼用于中重度斑块状银屑病治疗的临床应用价值
Ther Clin Risk Manag. 2023 May 18;19:413-423. doi: 10.2147/TCRM.S388324. eCollection 2023.
7
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation.中度至重度斑块状银屑病患者的比美吉珠单抗治疗:药物安全性评估
Expert Opin Drug Saf. 2023 Jan-Jun;22(5):355-362. doi: 10.1080/14740338.2023.2218086. Epub 2023 Jun 19.
8
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.罗氟司特乳膏与赋形剂乳膏治疗慢性斑块状银屑病的效果:DERMIS-1 和 DERMIS-2 随机临床试验。
JAMA. 2022 Sep 20;328(11):1073-1084. doi: 10.1001/jama.2022.15632.
9
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study.司库奇尤单抗治疗131例中重度斑块状银屑病患者的真实疗效及安全性:一项52周回顾性研究
Dermatol Ther (Heidelb). 2022 Oct;12(10):2309-2324. doi: 10.1007/s13555-022-00795-x. Epub 2022 Sep 5.
10
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.他卡西醇乳膏治疗斑块状银屑病 1 年的安全性和疗效:PSOARING 3 试验结果。
J Am Acad Dermatol. 2022 Oct;87(4):800-806. doi: 10.1016/j.jaad.2022.06.1171. Epub 2022 Jun 27.